- Investing Ideas
- Global Pharmaceuticals & Biotech High Risk Large Caps
Global Pharmaceuticals & Biotech High Risk Large Caps
Results
6
Are you holding one of these? A list of some of the most volatile large-cap stocks over the past five years.
6 companies
Natera
Market Cap: US$27.6b
A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.
NTRA
US$197.37
7D
-0.2%
1Y
31.7%
BioNTech
Market Cap: US$20.8b
Engages in the development and commercialization of immunotherapies in Germany.
BNTX
US$88.77
7D
-1.4%
1Y
-7.4%
Illumina
Market Cap: US$19.3b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
ILMN
US$126.20
7D
2.6%
1Y
52.4%
Sam Chun Dang Pharm
Market Cap: ₩25.9t
Engages in the manufacturing and sale of pharmaceutical products in South Korea.
A000250
₩1,115,000.00
7D
42.2%
1Y
510.6%
Elanco Animal Health
Market Cap: US$12.4b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$25.50
7D
2.7%
1Y
141.7%
Regencell Bioscience Holdings
Market Cap: US$12.1b
Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.
RGC
US$24.16
7D
-8.4%
1Y
2,266.2%